Shrimp Disease Diagnostics Market Research Report By Type of Disease (Bacterial Diseases, Viral Diseases, Parasitic Diseases, Fungal Diseases, Other Diseases), By Diagnostic Technique (Microscopy, Polymerase Chain Reaction (PCR), Loop-mediated Isothermal Amplification (LAMP), Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry), By Sample Type (Hemolymph, Tissue, Fecal, Water), By Application (Clinical Diagnostics, Surveillance, Research and Development), By End-User (Shrimp Farmers, Veterinarians, Researchers, Diagnostic Labora

Shrimp Disease Diagnostics Market Overview

As per MRFR analysis, the Shrimp Disease Diagnostics Market Size was estimated at 5.26 (USD Billion) in 2022. The Shrimp Disease Diagnostics Market Industry is expected to grow from 5.72(USD Billion) in 2023 to 12.1 (USD Billion) by 2032. The Shrimp Disease Diagnostics Market CAGR (growth rate) is expected to be around 8.68% during the forecast period (2024 - 2032).

Key Shrimp Disease Diagnostics Market Trends Highlighted

The Shrimp Disease Diagnostics Market is witnessing a surge in demand driven by advancements in molecular diagnostics, increasing shrimp farming, and rising awareness of disease prevention. As shrimp farming expands globally, the need for early and accurate disease detection intensifies. Molecular diagnostics, such as PCR and qPCR, offer rapid and sensitive methods for identifying specific pathogens responsible for shrimp diseases.

The incorporation of AI and machine learning into diagnostic platforms, which enables automated analysis and increased accuracy, is one of the emerging trends. Using biosensors to track the health of shrimp in real time is also becoming more popular. Furthermore, the creation of quick and non-invasive diagnostic techniques, including lateral flow tests, provides practical and affordable options for disease identification in the field.

The creation of multiplex diagnostic kits, which are capable of concurrently detecting numerous infections, presents opportunities for more market research. Pandemic monitoring and management are made easier by the remote data sharing and analysis made possible by the integration of diagnostic technology with cloud-based platforms. Collaborations between diagnostic firms and stakeholders in shrimp farming can also spur innovation and meet certain market demands.

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

Shrimp Disease Diagnostics Market Drivers

Rising Demand for Aquaculture Products

The world's growing population and increasing appetite for seafood have led to the expansion of aquaculture. In addition, shrimp farming has grown substantially since it provides nutritional benefits, is adaptable to diverse habitats, and has a relatively short growth period. Consequently, there has been a higher demand for highly accurate shrimp disease diagnostics as the industry looks to maintain shrimp health and productivity. Considering these factors, increased aquaculture is the force driving the expansion of the Shrimp Disease Diagnostics Market Industry.

Technological Advancements in Diagnostic Techniques

The shrimp disease diagnostics landscape has seen a drastic transformation with the advent of sophisticated diagnostic technologies. Techniques like PCR and LAMP have made disease detection more sensitive, specific, and fast. The use of biosensors, immunological assays, and other diagnostic innovations is another development. The improvement has contributed to the massive growth of the Shrimp Disease Diagnostics Market Industry.

Increasing Prevalence of Shrimp Diseases

The intensification of shrimp farming practices has led to an increased prevalence of diseases that can significantly impact shrimp health and productivity. Viral diseases, such as White Spot Syndrome Virus (WSSV) and Yellow Head Virus (YHV), have caused severe economic losses in the shrimp farming industry. Bacterial diseases, such as Vibriosis and Aeromonas Septicemia, are also prevalent and can result in high mortality rates. The rising incidence of shrimp diseases has fueled the demand for effective diagnostic tools to identify and control these diseases, driving the growth of the Shrimp Disease Diagnostics Market Industry.

Shrimp Disease Diagnostics Market Segment Insights

Shrimp Disease Diagnostics Market Type of Disease Insights  

Type of Disease The Shrimp Disease Diagnostics Market is segmented by type of disease into bacterial diseases, viral diseases, parasitic diseases, fungal diseases, and other diseases. Bacterial diseases accounted for the largest share of the market in 2023 and are expected to continue to dominate the market through 2032. This is due to the high prevalence of bacterial diseases in shrimp, such as vibriosis and streptococcosis. Viral diseases are the second-largest segment of the market and are also expected to grow at a significant rate over the forecast period.This is due to the increasing incidence of viral diseases in shrimp, such as white spot syndrome virus and yellow head virus. Parasitic diseases are the third-largest segment of the market and are expected to grow at a moderate rate over the forecast period. This is due to the increasing prevalence of parasitic diseases in shrimp, such as parasites and copepods. Fungal diseases are the fourth-largest segment of the market and are expected to grow at a slow rate over the forecast period. This is due to the low incidence of fungal diseases in shrimp.This growth is expected to be driven by the increasing demand for shrimp disease diagnostics due to the rising incidence of shrimp diseases, the growing awareness of the importance of shrimp disease prevention and control, and the increasing availability of advanced shrimp disease diagnostic technologies.

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

Shrimp Disease Diagnostics Market Diagnostic Technique Insights  

The shrimp disease diagnostics market is segmented by diagnostic technique into microscopy, polymerase chain reaction, loop-mediated isothermal amplification, enzyme-linked immunosorbent assay, and immunohistochemistry. With regard to shrimp disease diagnostics, microscopy is one of the most established techniques. This is likely because it is a simple and cost-effective technique. The polymerase chain reaction is a molecular technique that can amplify specific DNA sequences. It is one of the most sensitive and specific techniques for shrimp disease diagnostics.The loop-mediated isothermal amplification is another molecular technique, which is simpler and faster than the polymerase chain reaction. Being a rapid molecular technique, it has potential for point-of-care diagnostics. The enzyme-linked immunosorbent assay is an immunological technique where antibodies are used to detect the presence of specific antigens in shrimp samples. Finally, immunohistochemistry is a technique used to observe the distribution of antigens in shrimp tissue, which provides information about pathogenesis. In 2023, the microscopy segment held the largest revenue share in the shrimp disease diagnostics market.This is not surprising, as it is one of the most frequently used techniques. In addition, it is a simple and cheap technique. The polymerase chain reaction segment is expected to grow at the highest CAGR during the forecast period. This is likely due to the advances in molecular diagnostics and the increasing demand for high sensitivity and accuracy.

Shrimp Disease Diagnostics Market Sample Type Insights  

Hemolymph is the most common sample type used for shrimp disease diagnostics, as it is easy to collect and provides a good representation of the shrimp's overall health. Tissue samples are also commonly used, as they can provide more specific information about the disease. Fecal samples are less commonly used but can be helpful in diagnosing diseases that are shed through the feces. Water samples are used to test for the presence of pathogens in the environment. The hemolymph segment is expected to hold the largest share of the Shrimp Disease Diagnostics Market during the forecast period due to the ease of collection and the wide range of diseases that can be diagnosed using hemolymph samples.The tissue segment is expected to grow at a faster rate than the hemolymph segment due to the increasing use of tissue samples for more specific disease diagnosis.

Shrimp Disease Diagnostics Market Application Insights  

The 'Application' segment of the Shrimp Disease Diagnostics Market is categorized into Clinical Diagnostics, Surveillance, and Research and Development. Clinical Diagnostics accounted for the largest share of the market in 2023, owing to the increasing prevalence of shrimp diseases and the need for accurate and timely diagnosis to prevent further spread. The Surveillance segment is expected to witness significant growth over the forecast period, driven by the growing demand for monitoring shrimp health and preventing disease outbreaks. The Research and Development segment is anticipated to contribute to the market growth due to ongoing efforts to develop new and advanced diagnostic technologies.

Shrimp Disease Diagnostics Market End-User Insights  

The Shrimp Disease Diagnostics Market is segmented into various end-users, including shrimp farmers, veterinarians, researchers, and diagnostic laboratories. Among these segments, shrimp farmers account for a significant portion of the market revenue, driven by the need for accurate and timely disease diagnostics to ensure the health and productivity of their shrimp stocks. Veterinarians play a crucial role in providing diagnostic services to shrimp farmers, offering expertise in disease identification and treatment recommendations. Researchers contribute to the development and advancement of diagnostic technologies and methodologies, leading to improved accuracy and efficiency in disease detection.Diagnostic laboratories provide specialized testing services, leveraging advanced equipment and techniques to identify and characterize shrimp diseases. The market segmentation provides valuable insights into the specific needs and requirements of each end-user group, enabling targeted product development and marketing strategies.

Shrimp Disease Diagnostics Market Regional Insights  

Regional Insights Regionally, the Shrimp Disease Diagnostics Market is segmented into North America, Europe, APAC, South America, and MEA. APAC held the dominant market share in 2023 and is expected to maintain its position throughout the forecast period. The growth in the APAC region can be attributed to the increasing shrimp production and the rising awareness of shrimp diseases. North America is the second largest market for shrimp disease diagnostics, owing to the growing demand for shrimp and the presence of major shrimp producers in the region.Europe is also a significant market for shrimp disease diagnostics, with a large consumer base and a well-established aquaculture industry. South America and MEA are expected to witness moderate growth in the shrimp disease diagnostics market due to the increasing shrimp farming activities in these regions.

Source Primary Research, Secondary Research, MRFR Database and Analyst Review

Shrimp Disease Diagnostics Market Key Players And Competitive Insights

Major players in the Shrimp Disease Diagnostics Market industry are constantly striving to develop advanced diagnostic tools and technologies to meet the evolving needs of the shrimp farming industry. Leading Shrimp Disease Diagnostics Market players are investing in research and development to improve the accuracy, sensitivity, and specificity of their diagnostic tests. The Shrimp Disease Diagnostics Market development is driven by the growing demand for accurate and rapid disease detection methods to prevent and control shrimp diseases. The competitive landscape of the Shrimp Disease Diagnostics Market is highly competitive, with several established and emerging players. Some of the key companies operating in this market include IDEXX Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, and Merck.

One of the leading companies in the Shrimp Disease Diagnostics Market is IDEXX Laboratories. The company offers a comprehensive range of diagnostic tests for shrimp diseases, including PCR-based tests, ELISA tests, and lateral flow devices. IDEXX Laboratories has a strong presence and a well-established distribution network, which allows it to reach a wide range of customers. The company is also actively involved in research and development to expand its product portfolio and improve the accuracy of its diagnostic tests.A major competitor to IDEXX Laboratories in the Shrimp Disease Diagnostics Market is Bio-Rad Laboratories. Bio-Rad Laboratories offers a range of diagnostic tests for shrimp diseases, including PCR-based tests, real-time PCR tests, and loop-mediated isothermal amplification (LAMP) tests. The company has a strong focus on innovation and is constantly developing new and improved diagnostic technologies. Bio-Rad Laboratories also has a presence and a well-established distribution network, which allows it to reach a wide range of customers.

Key Companies in the Shrimp Disease Diagnostics Market Include

• Merck KGaA


• Promega Corporation


• Thermo Fisher Scientific


• BioTechne


• QIAGEN


• Zoetis


• Abcam plc


• Mérieux NutriSciences


• BioRad Laboratories


• PerkinElmer


• Neogen Corporation


• BioMérieux


• Fujifilm Wako Diagnostics


• IDEXX Laboratories


• GenScript Biotech Corporation

Shrimp Disease Diagnostics Market Industry Developments

The shrimp disease diagnostics market is projected to reach USD 12.1 billion by 2032, exhibiting a CAGR of 8.68% during the forecast period. Rising shrimp production and increasing prevalence of shrimp diseases are key factors driving market growth. Technological advancements, such as the development of rapid and accurate diagnostic tests, are also contributing to market expansion.Recent developments in the market include In 2023, Thermo Fisher Scientific launched the Applied Biosystems TaqPath Shrimp Multi-pathogen PCR Kit, a multiplex PCR test for the simultaneous detection of multiple shrimp pathogens. In 2022, Bio-Rad Laboratories acquired Celsee, a provider of molecular diagnostics solutions for aquaculture, strengthening its portfolio of shrimp disease diagnostic products. Governments worldwide are implementing stricter regulations to control the spread of shrimp diseases, creating opportunities for market players.Asia-Pacific is the largest market for shrimp disease diagnostics, driven by high shrimp production and consumption in the region. North America and Europe are also significant markets, with increasing adoption of advanced diagnostic technologies.

Shrimp Disease Diagnostics Market Segmentation Insights

Shrimp Disease Diagnostics Market Type of Disease Outlook

• Bacterial Diseases


• Viral Diseases


• Parasitic Diseases


• Fungal Diseases


• Other Diseases

Shrimp Disease Diagnostics Market Diagnostic Technique Outlook

• Microscopy


• Polymerase Chain Reaction (PCR)


• Loop-mediated Isothermal Amplification (LAMP)


• Enzyme-Linked Immunosorbent Assay (ELISA)


• Immunohistochemistry

Shrimp Disease Diagnostics Market Sample Type Outlook

• Hemolymph


• Tissue


• Fecal


• Water

Shrimp Disease Diagnostics Market Application Outlook

• Clinical Diagnostics


• Surveillance


• Research and Development

Shrimp Disease Diagnostics Market End-User Outlook

• Shrimp Farmers


• Veterinarians


• Researchers


• Diagnostic Laboratories

Shrimp Disease Diagnostics Market Regional Outlook

• North America


• Europe


• South America


• Asia-Pacific


• Middle East and Africa